Drug misuse and dependency

Sign up for updates to this topic page

On this page

Services

• NDTMS: secure setting outcomes forms

  Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.

• NDTMS: community combined review forms

  Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.

See more services in this topic

Guidance and regulation

• Controlled drugs list
  • Guidance
  • 2 December 2019
  • Home Office
• COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
  • Guidance
  • 16 September 2020
  • Public Health England and Department of Health and Social Care
• Home Office approved testing kits: annex A
  • Guidance
  • 4 August 2014
  • Home Office
• Drug misuse and dependence: UK guidelines on clinical management
  • Guidance
  • 15 December 2017
  • Department of Health and Social Care
• Precursor chemical licensing
  • Detailed guide
  • 18 February 2020
  • Home Office

See more guidance and regulation in this topic

News and communications

8 September 2020 — Correspondence

Response to the ACMD report on novel benzodiazepines

Home Office and Advisory Council on the Misuse of Drugs

• Three new benzodiazepines to become Class C drugs
  • 8 September 2020
  • Home Office
  • News story
• ACMD work programme 2020 to 2022: commissioning letter
  • 12 August 2020
  • Home Office
  • Correspondence
• New appointments to the ACMD
  • 3 August 2020
  • Advisory Council on the Misuse of Drugs
  • News story
• Government launches second phase of independent review into drug misuse
  • 2 July 2020
  • Department of Health and Social Care
  • Press release

See more news and communications in this topic

Research and statistics

• United Kingdom drug situation: Focal Point annual report
  • 10 August 2020
  • Public Health England, Home Office, Welsh Government, The Scottish Government, Public Health Wales, and Department of Health (Northern Ireland)
  • Research
• Novel benzodiazepines: prevalence and harms in the UK
  • 29 April 2020
  • Advisory Council on the Misuse of Drugs
  • Research
• Substance misuse treatment in secure settings: 2018 to 2019
  • 30 January 2020
  • Public Health England
  • Official statistics
• Shooting Up: infections among people who inject drugs in the UK
  • 17 December 2019
  • Public Health England
  • Research
• Substance misuse treatment for young people: statistics 2018 to 2019
  • 28 November 2019
  • Public Health England
  • National statistics

See more research and statistics in this topic

Policy papers and consultations

• Independent review of drugs: call for evidence, part 2
  • 2 July 2020
  • Department of Health and Social Care
  • Closed consultation
  • Date closed 07 August 2020
• NDTMS annual reports and methodology: proposed changes
  • 24 September 2019
  • Public Health England
  • Consultation outcome
  • Date closed 25 August 2019
• ACMD ageing cohort of drug users report: government response
  • 3 October 2019
  • Department of Health and Social Care
  • Policy paper
• Drug related harms in homeless populations: government response
  • 19 September 2019
  • Ministry of Housing, Communities & Local Government and Department of Health and Social Care
  • Policy paper
• Drugs policy and medicinal cannabis report: government response
  • 6 September 2019
  • Department of Health and Social Care
  • Policy paper

See more policy papers and consultations in this topic

Transparency and freedom of information releases

• Standard Operating Procedure for using evidence in ACMD reports
  • 26 March 2020
  • Advisory Council on the Misuse of Drugs
  • Corporate report
• Commissioning impact on drug treatment
  • 6 September 2017
  • Advisory Council on the Misuse of Drugs
  • Corporate report
• Drug strategy 2016: development review
  • 13 July 2017
  • Advisory Council on the Misuse of Drugs
  • Corporate report
• Psychoactive Substances Bill: evaluation review
  • 13 July 2017
  • Advisory Council on the Misuse of Drugs
  • Corporate report
• Methiopropamine: a review of the evidence of use and harm
  • 16 June 2017
  • Advisory Council on the Misuse of Drugs
  • Corporate report

See more transparency and freedom of information releases in this topic

Organisations

1. Home Office
2. Public Health England
3. Department of Health & Social Care
4. Department for Work & Pensions
5. Department for Transport

Show more organisations

1. Prime Minister's Office, 10 Downing Street
2. Ministry of Justice
3. Department for Digital, Culture, Media & Sport
4. Medicines & Healthcare products Regulatory Agency
5. Ministry of Housing, Communities & Local Government

• Advisory Council on the Misuse of Drugs